Canada has become the epicenter of the cannabis industry with the country-wide legalization of medical and soon-to-be recreational marijuana. In fact, Deloitte projects that Canadian cannabis and related revenue could eclipse the combined sales of beer, wine and spirits at $22.6 billion per year. Justin Trudeau’s liberal government may be the driver behind these drug laws, but the drug’s legalization has been carefully planned from start to finish.
In December, the Canadian Cannabis Task Force issued its final report that contains more than 80 recommendations for the government to consider when legalizing recreational marijuana. Section 4.5 of the final report describes the controversy surrounding marijuana-impaired driving and the public safety risks. In addition to discussing these risks, the report made several recommendations for addressing the key issue before legalizing the drug.
In this article, we will take a look at the final report and why Cannabix Technologies Inc. (CSE: BLO) (OTC: BLOZF) is well-positioned to capitalize on the recommendations.
Impaired Driving Regulations
Marijuana-impaired driving has become a major concern in countries where the drug has been legalized for medical and/or recreational use. Most scientists agree that tetrahydrocannabinol (THC) impairs driving ability, but the level of THC in bodily fluids cannot be reliably used to indicate the degree of impairment. Most experts agree that per se limits are appropriate in the case of driving laws despite these uncertainties about actual impairment.
The Canadian Cannabis Task Force made seven specific recommendations to the government to address impaired driving. Many of these recommendations are focused on setting the right limits and training officers to recognize impairment, but others are designed to spur the development of specific technologies. The latter recommendations could create opportunities for companies involved in areas of drug detection and related fields.
In particular, the fifth recommendation issued by the task for reads: